Atlas Trials

Effects of Intranasal Oxytocin on Satiety Signaling in People With Schizophrenia

Clinical trial NCT01614093 · COMPLETED

Trial details

NCT number
NCT01614093
Sponsor
University of Maryland, Baltimore
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Schizophrenia
Start date
2012-06-01
Primary completion
2014-01-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.